BioSpace News Archive

Drug Development

Potential Cancer “Vaccine” Shows Promise in Early-Stage NHL Trial

Researchers with the Icahn School of Medicine at Mount Sinai in New York have had promising results with a cancer vaccine in an early-stage clinical trial. They published their work in the journal Nature Medicine.

April 9, 2019
·
2 min read
·
Mark Terry
Job Trends

Biopharma Incubators and Accelerators Play a Significant Role in Creating Regional Growth

Life science incubators and accelerators play a highly significant role in the industry and may be the key for regional growth, a new report shows.

April 9, 2019
·
2 min read
·
Alex Keown
Policy

PhaseBio Receives FDA Breakthrough Therapy Designation and Licenses GLP-1 Analog to ImmunoForge

PhaseBio Pharmaceuticals, based in Malvern, Penn. and San Diego, announced that its antiplatelet drug PB2452 had received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

April 9, 2019
·
3 min read
·
Mark Terry
Business

Out From Under Novartis, Alcon Is Its Own Company Now

Alcon CEO says the company is “poised to achieve sustainable growth and create long-term shareholder value as a standalone company.”

April 9, 2019
·
3 min read
·
Alex Keown
Job Trends

Amidst Massive Global Job Cuts, Bayer Expands in Boston

At the same time that Bayer AG announced it was planning to eliminate about 4,500 jobs in Germany, it is adding about 150 jobs over the next three years in Massachusetts.

April 9, 2019
·
2 min read
·
Mark Terry
BioMidwest

AbbVie Takes Top Spot in Best Place to Work Survey

The study, which uses data gathered from Great Places to Work, points to the company’s openness from its leadership and the treatment of its employees as the primary reason it took the top spot.

April 9, 2019
·
2 min read
·
Alex Keown
Business

New Express Scripts Program Caps Insulin Costs for 30-Day Supplies at $25

The new program will ensure eligible people with diabetes in participating plans pay no more than $25 for a 30-day supply of insulin.

April 9, 2019
·
3 min read
·
Alex Keown
Deals

Pharming Group announces completion of minority investment in BioConnection BV

Pharming has acquired its shareholding through the conversion of €2.5 million of existing credits and €1.6 million of new cash subscription for a total of €4.1 million in BioConnection shares, plus additional shares acquired from existing investors.

April 9, 2019
·
5 min read
Business

Polyphor appoints Gökhan Batur as Chief Commercial Officer

Polyphor AG, a clinical stage, Swiss biopharmaceutical company focused on the discovery and development of antibiotics and immuno-oncology compounds announced the appointment of Gökhan Batur to the newly created position of Chief Commercial Officer.

April 9, 2019
·
3 min read
Policy

A*STAR scientists discover two distinct types of macrophages within interstitial tissues

The distinct roles of these immune cells opens the possibility of new treatments for human inflammatory diseases

April 9, 2019
·
5 min read